GENETIC · Unmapped registry intervention
Vectra MBDA Test
Find medicine records ·
Find other trials using this name
Clinical trial
Impact of Guided Care With the Vectra Multi-biomarker Disease Activity (MBDA) Blood Test
NCT03810144
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedImpact of Guided Care With the Vectra Multi-biomarker Disease Activity (MBDA) Blood Test
Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
Vectra MBDA TestGENETIC
Sponsors & collaborators
Sequenom, Inc.lead sponsor
Laboratory Corporation of Americacollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03810144 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.